TROD Medical is a medical device company that is focused on the development of radio frequency ablation technologies. The company is headquartered in Leuven, Belgium, and Tampa Bay area, USA. Incepted in 2006 by Dr. Andre Faure, TROD Medical has developed significant expertise in developing innovative ablation technologies, particularly Radio Frequency (RF) ablation devices. TROD Medical has developed a disruptive percutaneous RF device, the EncageTM, that is able to ablate tissues with a degree of precision unmatched by competition. The technology represents a major breakthrough in treatments where collateral tissue damage is a significant burden to patients, like prostate cancer.
Revolutionizing Prostate Cancer Treatment
Prostate cancer is one of the most common cancers, with around 240,000 new cases per year in the US alone. Unfortunately, the commonly used treatments for prostate cancer, such as surgery and radiation therapy, can lead to significant side effects like erectile dysfunction and urinary incontinence. These side effects can have a profound impact on the quality of life of patients. TROD Medical’s EncageTM is a game-changer in the treatment of prostate cancer. The device is able to ablate tissues with a degree of precision that is unmatched by other RF ablation devices. This precision means that collateral tissue damage is significantly reduced, leading to fewer side effects for patients. The EncageTM is a minimally invasive procedure, which means that patients can recover more quickly than they would with traditional surgery.
TROD Medical’s RF ablation technology can also be used to treat other conditions, such as liver, lung, and kidney cancer. The EncageTM device has been successfully used in clinical trials, and TROD Medical is in the process of obtaining regulatory approval to bring the device to market.
Investing in Innovation
TROD Medical’s innovative technology has the potential to revolutionize the way that cancer is treated. The company has a strong team of researchers and medical professionals who are dedicated to developing cutting-edge medical devices that improve the lives of patients. TROD Medical has already attracted significant investment, and the company is poised for rapid growth as its products reach the market.
If you’re interested in investing in TROD Medical, or if you’re a medical professional interested in using the company’s products, you can learn more by visiting the TROD Medical website or following the company on social media.
In conclusion, TROD Medical is a medical device company that is at the forefront of developing innovative radio frequency ablation technologies. Its EncageTM device has the potential to revolutionize the treatment of prostate cancer, and the company is poised for rapid growth as its products reach the market.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!